Cioffi Christiana Marie 4

What Happened
Christiana Marie Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals, had 156 shares released from restriction and reported as an acquisition on 2026-05-31. The Form 4 records the shares at $0.00 per share (aggregate $0), indicating a release/settlement of previously awarded restricted stock rather than a market purchase or sale.

Key Details

• Transaction date: 2026-05-31
• Filing date: 2026-06-01 (filed promptly/timely)
• Transaction type/code: Award/release of restricted shares (code A)
• Shares acquired: 156 @ $0.00; aggregate reported value $0
• Footnote: F1 — shares released from restriction from shares awarded 3/28/2025
• Shares owned after transaction: Not disclosed in the provided filing excerpt

Context
This was a vesting/release of previously granted restricted stock (compensation), not an open-market buy or sale. Such releases are routine forms of executive compensation and do not by themselves signal a trading view; purchases are generally more informative about insider sentiment. Once restrictions are lifted, the shares may be sellable subject to company policies and blackout periods.